Skip to content

BBLG BONE BIOLOGICS CORP

Follow

COM (common), issuer CIK 1419554

3 managers (3 13F filers) reported a position in BBLG shares at 2026-06-30, 26,062 shares in all. 1 filer opened a position and 1 filer sold out during the quarter.

Managers
3
13F filers
3
New
1
Added
0
Reduced
1
Sold out
1
Shares held by filers
26,062

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

Each filer's latest stake. The shares are the aggregate the reporting persons state, which can include entities that file no 13F.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
CITADEL ADVISORS LLCin group CITADEL ADVISORS LLC23,879$32.7K<0.01%new13F-HR/ATimelineGroup
Tower Research Capital LLC (TRC)in group Tower Research Capital LLC (T…1,953$2.68K<0.01%-2,17313F-HRTimelineGroup
SBI Securities Co., Ltd.230$315<0.01%013F-HRTimeline

Events

  • ARMISTICE CAPITAL, LLC and 1 other reporting person reported 343,957 BBLG shares, 9.99% of the class, as of 2026-09-30, in a 13G filed 2026-11-16. 0001172661-26-005213

    Accepted , ingested
  • INTRACOASTAL CAPITAL, LLC and 2 other reporting persons reported 305,888 BBLG shares, 9.99% of the class, as of 2026-09-30, in a 13G/A filed 2026-11-10. 0001213900-26-118156

    Accepted , ingested